INVA vs REGN: Which Stock is Better?
Side-by-side comparison of Innoviva Inc and Regeneron Pharmaceuticals Inc in 2026
INVA
Innoviva Inc
$23.60
REGN
Regeneron Pharmaceuticals Inc
$746.00
Key Metrics Comparison
| Metric | INVA | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.79B | $79.71B | REGN |
| P/E Ratio | 7.34 | 18.18 | INVA |
| EPS (TTM) | $3.26 | $41.47 | REGN |
| Revenue Growth | 0.2% | 0.0% | INVA |
| Gross Margin | 74.9% | 44.6% | INVA |
Analyze INVA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INVA or REGN a better investment?
Comparing INVA and REGN: Innoviva Inc has a market cap of $1.79B while Regeneron Pharmaceuticals Inc has $79.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INVA and REGN?
INVA (Innoviva Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INVA or REGN?
Based on P/E ratios, INVA trades at a lower multiple (7.3x vs 18.2x).
Which is growing faster: INVA or REGN?
INVA has higher revenue growth at 0.2% vs 0.0% for REGN.
Which company is more profitable: INVA or REGN?
Innoviva Inc (INVA) has higher gross margins at 74.9% compared to 44.6% for REGN.
Which is the larger company: INVA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.71B compared to $1.79B for INVA.
Should I buy INVA or REGN in 2026?
Both INVA and REGN have investment merit. INVA trades at $23.60 while REGN trades at $746.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INVA and REGN stock?
Key differences: Market Cap ($1.79B vs $79.71B), P/E Ratio (7.3x vs 18.2x), Revenue Growth (0.2% vs 0.0%), Gross Margin (74.9% vs 44.6%).